$4.93 Billion is the total value of Artal Group S.A.'s 146 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 27.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
WW | WW INTL INC | $535,533,000 | +15.5% | 14,818,300 | 0.0% | 10.87% | +32.7% | |
LXRX | LEXICON PHARMACEUTICALS INC | $326,708,000 | -21.8% | 71,178,364 | 0.0% | 6.63% | -10.2% | |
BGNE | BEIGENE LTDsponsored adr | $291,712,000 | -1.4% | 850,000 | 0.0% | 5.92% | +13.3% | |
C | Sell | CITIGROUP INCcall | $194,563,000 | -10.9% | 2,750,000 | -8.3% | 3.95% | +2.4% |
SEER | SEER INC | $183,187,000 | -34.5% | 5,588,366 | 0.0% | 3.72% | -24.7% | |
XLRN | ACCELERON PHARMA INC | $175,686,000 | -7.5% | 1,400,000 | 0.0% | 3.57% | +6.3% | |
ARGX | Buy | ARGENX SEsponsored adr | $150,535,000 | +21.5% | 500,000 | +11.1% | 3.06% | +39.5% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $137,301,000 | +10.6% | 850,000 | +17.2% | 2.79% | +27.0% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $127,140,000 | +20.1% | 750,000 | 0.0% | 2.58% | +37.9% | |
GM | Sell | GENERAL MTRS COcall | $118,340,000 | -41.2% | 2,000,000 | -42.9% | 2.40% | -32.4% |
FATE | Buy | FATE THERAPEUTICS INC | $117,167,000 | +9.3% | 1,350,000 | +3.8% | 2.38% | +25.6% |
RUBY | Sell | RUBIUS THERAPEUTICS INC | $113,111,000 | -12.6% | 4,633,791 | -5.1% | 2.30% | +0.4% |
MORF | MORPHIC HLDG INC | $104,403,000 | -9.3% | 1,819,186 | 0.0% | 2.12% | +4.2% | |
IGMS | Sell | IGM BIOSCIENCES INC | $91,520,000 | +6.1% | 1,100,000 | -2.2% | 1.86% | +21.9% |
GBIO | GENERATION BIO CO | $75,702,000 | -5.5% | 2,814,191 | 0.0% | 1.54% | +8.6% | |
INTC | INTEL CORPcall | $72,982,000 | -12.3% | 1,300,000 | 0.0% | 1.48% | +0.7% | |
BMY | BRISTOL-MYERS SQUIBB COcall | $66,820,000 | +5.8% | 1,000,000 | 0.0% | 1.36% | +21.6% | |
IMAB | I MABsponsored ads | $62,963,000 | +73.2% | 750,000 | 0.0% | 1.28% | +99.1% | |
SDGR | SCHRODINGER INC | $60,295,000 | -0.9% | 797,445 | 0.0% | 1.22% | +13.9% | |
SRRK | SCHOLAR ROCK HLDG CORP | $57,800,000 | -43.0% | 2,000,000 | 0.0% | 1.17% | -34.5% | |
SAGE | Buy | SAGE THERAPEUTICS INC | $56,810,000 | +16.8% | 1,000,000 | +53.8% | 1.15% | +34.1% |
F | Sell | FORD MTR CO DELcall | $52,010,000 | -39.3% | 3,500,000 | -50.0% | 1.06% | -30.3% |
CERE | Sell | CEREVEL THERAPEUTICS HLDNG I | $51,240,000 | +49.3% | 2,000,000 | -20.0% | 1.04% | +71.6% |
ALVR | ALLOVIR INC | $45,863,000 | -15.6% | 2,323,371 | 0.0% | 0.93% | -3.1% | |
SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $41,205,000 | +40.0% | 500,000 | +25.0% | 0.84% | +60.8% |
NTLA | INTELLIA THERAPEUTICS INC | $40,478,000 | +101.7% | 250,000 | 0.0% | 0.82% | +131.5% | |
DNLI | DENALI THERAPEUTICS INC | $39,220,000 | +37.4% | 500,000 | 0.0% | 0.80% | +57.9% | |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $38,832,000 | – | 400,000 | +100.0% | 0.79% | – |
OTLY | New | OATLY GROUP ABsponsored ads | $36,690,000 | – | 1,500,000 | +100.0% | 0.74% | – |
FOLD | AMICUS THERAPEUTICS INC | $36,150,000 | -2.4% | 3,750,000 | 0.0% | 0.73% | +12.1% | |
REPL | Buy | REPLIMUNE GROUP INC | $34,578,000 | +41.7% | 900,000 | +12.5% | 0.70% | +62.9% |
KRYS | KRYSTAL BIOTECH INC | $34,000,000 | -11.7% | 500,000 | 0.0% | 0.69% | +1.3% | |
AGEN | AGENUS INC | $32,940,000 | +101.8% | 6,000,000 | 0.0% | 0.67% | +132.3% | |
KRON | KRONOS BIO INC | $31,565,000 | -18.2% | 1,317,954 | 0.0% | 0.64% | -6.0% | |
TGTX | Sell | TG THERAPEUTICS INC | $31,032,000 | -57.1% | 800,000 | -46.7% | 0.63% | -50.7% |
TALS | New | TALARIS THERAPEUTICS INC | $30,324,000 | – | 2,064,262 | +100.0% | 0.62% | – |
VERV | New | VERVE THERAPEUTICS INC | $30,125,000 | – | 500,000 | +100.0% | 0.61% | – |
DRNA | DICERNA PHARMACEUTICALS INC | $29,856,000 | +46.0% | 800,000 | 0.0% | 0.61% | +67.9% | |
FCX | Sell | FREEPORT-MCMORAN INCcall | $27,833,000 | -15.5% | 750,000 | -25.0% | 0.56% | -2.9% |
ALXO | Sell | ALX ONCOLOGY HLDGS INC | $27,340,000 | -29.4% | 500,000 | -4.8% | 0.56% | -18.9% |
TPTX | Buy | TURNING POINT THERAPEUTICS I | $27,307,000 | -7.7% | 350,000 | +11.9% | 0.55% | +5.9% |
ITOS | Sell | ITEOS THERAPEUTICS INC | $25,497,000 | -31.8% | 994,047 | -9.1% | 0.52% | -21.8% |
FMTX | FORMA THERAPEUTICS HLDGS INC | $24,890,000 | -11.2% | 1,000,000 | 0.0% | 0.50% | +2.0% | |
TRILLIUM THERAPEUTICS INC | $24,250,000 | -9.7% | 2,500,000 | 0.0% | 0.49% | +3.8% | ||
CAR | Sell | AVIS BUDGET GROUP | $23,367,000 | -28.4% | 300,000 | -33.3% | 0.47% | -17.9% |
ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $23,325,000 | -18.8% | 1,500,000 | -25.0% | 0.47% | -6.7% |
SQZ | SQZ BIOTECHNOLOGIES CO | $23,211,000 | +5.6% | 1,606,309 | 0.0% | 0.47% | +21.4% | |
ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $22,080,000 | -40.8% | 2,255,375 | 0.0% | 0.45% | -32.1% | |
TSHA | TAYSHA GENE THERAPIES INC | $22,067,000 | +4.4% | 1,040,882 | 0.0% | 0.45% | +20.1% | |
PRAX | Buy | PRAXIS PRECISION MEDICINES I | $21,936,000 | -10.7% | 1,200,000 | +60.0% | 0.44% | +2.5% |
IKNA | IKENA ONCOLOGY INC | $21,755,000 | -50.3% | 1,549,513 | 0.0% | 0.44% | -42.8% | |
GRPH | New | GRAPHITE BIO INC | $21,511,000 | – | 700,000 | +100.0% | 0.44% | – |
ALBO | ALBIREO PHARMA INC | $21,108,000 | -0.2% | 600,000 | 0.0% | 0.43% | +14.4% | |
NG | NOVAGOLD RES INC | $20,826,000 | -8.6% | 2,600,000 | 0.0% | 0.42% | +5.2% | |
BDTX | BLACK DIAMOND THERAPEUTICS I | $20,071,000 | -49.8% | 1,646,517 | 0.0% | 0.41% | -42.4% | |
NEXI | NEXIMMUNE INC | $19,584,000 | -14.5% | 1,200,000 | 0.0% | 0.40% | -2.0% | |
GOSS | GOSSAMER BIO INC | $19,155,000 | -12.2% | 2,358,968 | 0.0% | 0.39% | +0.8% | |
FHTX | FOGHORN THERAPEUTICS INC | $18,360,000 | -19.0% | 1,720,720 | 0.0% | 0.37% | -7.0% | |
Buy | MARINUS PHARMACEUTICALS INC | $17,940,000 | +44.9% | 1,000,000 | +25.0% | 0.36% | +66.2% | |
APTX | APTINYX INC | $17,310,000 | -5.7% | 6,116,493 | 0.0% | 0.35% | +8.3% | |
RPTX | REPARE THERAPEUTICS INC | $17,149,000 | +1.6% | 550,000 | 0.0% | 0.35% | +16.8% | |
BBIO | Buy | BRIDGEBIO PHARMA INC | $16,764,000 | +8.9% | 275,000 | +10.0% | 0.34% | +25.0% |
SELB | Sell | SELECTA BIOSCIENCES INC | $16,720,000 | -17.9% | 4,000,000 | -11.1% | 0.34% | -5.8% |
AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $16,660,000 | – | 850,000 | +100.0% | 0.34% | – |
MRSN | MERSANA THERAPEUTICS INC | $16,296,000 | -16.1% | 1,200,000 | 0.0% | 0.33% | -3.5% | |
ZYME | ZYMEWORKS INC | $15,611,000 | +9.9% | 450,000 | 0.0% | 0.32% | +26.3% | |
IQ | Sell | IQIYI INCsponsored ads | $15,580,000 | -8.5% | 1,000,000 | -2.4% | 0.32% | +5.0% |
DLO | New | DLOCAL LTD | $15,496,000 | – | 295,000 | +100.0% | 0.32% | – |
BLU | BELLUS HEALTH INC NEW | $14,773,000 | -19.0% | 4,750,000 | 0.0% | 0.30% | -6.8% | |
RLAY | RELAY THERAPEUTICS INC | $14,636,000 | +5.8% | 400,000 | 0.0% | 0.30% | +21.7% | |
LFST | New | LIFESTANCE HEALTH GROUP INC | $13,930,000 | – | 500,000 | +100.0% | 0.28% | – |
HARP | HARPOON THERAPEUTICS INC | $13,870,000 | -33.7% | 1,000,000 | 0.0% | 0.28% | -23.8% | |
NBTX | NANOBIOTIX SAsponsored ads | $13,780,000 | -8.4% | 1,000,000 | 0.0% | 0.28% | +5.3% | |
TBIO | Sell | TRANSLATE BIO INC | $13,770,000 | -16.5% | 500,000 | -50.0% | 0.28% | -4.1% |
EVLO | EVELO BIOSCIENCES INC | $13,740,000 | +28.4% | 1,000,000 | 0.0% | 0.28% | +47.6% | |
ADAG | Buy | ADAGENE INCads | $13,560,000 | -5.6% | 1,000,000 | +25.0% | 0.28% | +8.3% |
YMAB | Y-MABS THERAPEUTICS INC | $13,520,000 | +11.8% | 400,000 | 0.0% | 0.27% | +28.0% | |
AUPH | AURINIA PHARMACEUTICALS INC | $12,960,000 | -0.2% | 1,000,000 | 0.0% | 0.26% | +14.8% | |
KURA | KURA ONCOLOGY INC | $12,510,000 | -26.2% | 600,000 | 0.0% | 0.25% | -15.3% | |
TCRR | TCR2 THERAPEUTICS INC | $12,308,000 | -25.7% | 750,000 | 0.0% | 0.25% | -14.7% | |
AGL | New | AGILON HEALTH INC | $12,171,000 | – | 300,000 | +100.0% | 0.25% | – |
KYMR | KYMERA THERAPEUTICS INC | $12,125,000 | +24.8% | 250,000 | 0.0% | 0.25% | +43.0% | |
LYEL | New | LYELL IMMUNOPHARMA INC | $11,368,000 | – | 700,000 | +100.0% | 0.23% | – |
DYN | DYNE THERAPEUTICS INC | $11,046,000 | +35.5% | 525,000 | 0.0% | 0.22% | +55.6% | |
CYCN | Buy | CYCLERION THERAPEUTICS INC | $10,838,000 | +113.7% | 2,779,122 | +52.9% | 0.22% | +144.4% |
ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $10,500,000 | -55.6% | 3,000,000 | +25.0% | 0.21% | -49.0% |
CRIS | Sell | CURIS INC | $10,491,000 | -48.6% | 1,300,000 | -28.0% | 0.21% | -41.0% |
VOR | VOR BIOPHARMA INC | $10,258,000 | -56.7% | 550,000 | 0.0% | 0.21% | -50.4% | |
CYTK | New | CYTOKINETICS INC | $9,895,000 | – | 500,000 | +100.0% | 0.20% | – |
OVID | OVID THERAPEUTICS INC | $9,775,000 | -2.7% | 2,500,000 | 0.0% | 0.20% | +11.2% | |
SYRS | Buy | SYROS PHARMACEUTICALS INC | $9,265,000 | +20.8% | 1,700,000 | +65.9% | 0.19% | +39.3% |
BPMC | New | BLUEPRINT MEDICINES CORP | $8,796,000 | – | 100,000 | +100.0% | 0.18% | – |
YI | 111 INCads | $8,779,000 | -34.2% | 966,349 | 0.0% | 0.18% | -24.6% | |
TIL | INSTIL BIO INC | $8,694,000 | -23.0% | 450,000 | 0.0% | 0.18% | -11.6% | |
IMUX | IMMUNIC INC | $8,582,000 | -23.1% | 700,000 | 0.0% | 0.17% | -11.7% | |
STOK | STOKE THERAPEUTICS INC | $8,415,000 | -13.3% | 250,000 | 0.0% | 0.17% | -0.6% | |
APLT | APPLIED THERAPEUTICS INC | $8,312,000 | +10.8% | 400,000 | 0.0% | 0.17% | +27.1% | |
SLDB | SOLID BIOSCIENCES INC | $8,235,000 | -33.8% | 2,250,000 | 0.0% | 0.17% | -24.1% | |
DSGN | DESIGN THERAPEUTICS INC | $7,956,000 | -33.5% | 400,000 | 0.0% | 0.16% | -23.7% | |
ACIU | AC IMMUNE SA | $7,930,000 | +4.2% | 1,000,000 | 0.0% | 0.16% | +20.1% | |
ORTX | ORCHARD THERAPEUTICS PLCads | $7,919,000 | -39.5% | 1,803,858 | 0.0% | 0.16% | -30.3% | |
SANA | SANA BIOTECHNOLOGY INC | $7,864,000 | -41.3% | 400,000 | 0.0% | 0.16% | -32.5% | |
ARAV | ARAVIVE INC | $7,842,000 | -9.2% | 1,311,291 | 0.0% | 0.16% | +3.9% | |
IMCR | IMMUNOCORE HLDGS PLCads | $7,810,000 | -8.3% | 200,000 | 0.0% | 0.16% | +6.0% | |
OMEG | OMEGA ALPHA SPACcl a | $7,463,000 | +0.5% | 750,000 | 0.0% | 0.15% | +15.3% | |
DCPH | DECIPHERA PHARMACEUTICALS IN | $7,322,000 | -18.4% | 200,000 | 0.0% | 0.15% | -5.7% | |
RXRX | New | RECURSION PHARMACEUTICALS INcl a | $7,300,000 | – | 200,000 | +100.0% | 0.15% | – |
OLMA | OLEMA PHARMACEUTICALS INC | $7,289,000 | -15.7% | 260,500 | 0.0% | 0.15% | -3.3% | |
AGLE | AEGLEA BIOTHERAPEUTICS INC | $7,273,000 | -12.1% | 1,045,000 | 0.0% | 0.15% | +1.4% | |
ORIC | Buy | ORIC PHARMACEUTICALS INC | $7,076,000 | +188.8% | 400,000 | +300.0% | 0.14% | +234.9% |
SPRO | SPERO THERAPEUTICS INC | $6,980,000 | -5.2% | 500,000 | 0.0% | 0.14% | +9.2% | |
CFRX | CONTRAFECT CORP | $6,600,000 | -8.3% | 1,500,000 | 0.0% | 0.13% | +5.5% | |
FUSN | Buy | FUSION PHARMACEUTICALS INC | $6,060,000 | +4.8% | 750,000 | +39.1% | 0.12% | +20.6% |
HOOK | HOOKIPA PHARMA INC | $5,492,000 | -31.9% | 599,616 | 0.0% | 0.11% | -21.8% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $5,337,000 | -15.1% | 593,030 | 0.0% | 0.11% | -2.7% | |
BHG | New | BRIGHT HEALTH GROUP INC | $5,243,000 | – | 305,555 | +100.0% | 0.11% | – |
DYNS | New | DYNAMICS SPECIAL PURPOSE COR | $4,970,000 | – | 500,000 | +100.0% | 0.10% | – |
CRDF | CARDIFF ONCOLOGY INC | $4,988,000 | -28.2% | 750,000 | 0.0% | 0.10% | -17.9% | |
LPTX | LEAP THERAPEUTICS INC | $4,920,000 | -13.7% | 3,000,000 | 0.0% | 0.10% | -1.0% | |
ALDX | New | ALDEYRA THERAPEUTICS INC | $4,893,000 | – | 431,894 | +100.0% | 0.10% | – |
MREO | MEREO BIOPHARMA GROUP PLCads | $4,755,000 | -5.9% | 1,500,000 | 0.0% | 0.10% | +9.0% | |
MCRB | SERES THERAPEUTICS INC | $4,770,000 | +15.8% | 200,000 | 0.0% | 0.10% | +32.9% | |
IMMP | New | IMMUTEP LTDsponsored ads | $3,870,000 | – | 1,000,000 | +100.0% | 0.08% | – |
KLDO | KALEIDO BIOSCIENCES INC | $3,724,000 | -8.1% | 500,500 | 0.0% | 0.08% | +5.6% | |
CDAK | CODIAK BIOSCIENCES INC | $3,706,000 | +22.9% | 200,000 | 0.0% | 0.08% | +41.5% | |
RNA | AVIDITY BIOSCIENCES INC | $3,521,000 | +13.3% | 142,500 | 0.0% | 0.07% | +29.1% | |
MTCR | METACRINE INC | $3,515,000 | -38.7% | 924,898 | 0.0% | 0.07% | -29.7% | |
VIAC | Buy | VIACOMCBS INCcl b | $3,390,000 | +11.4% | 75,000 | +11.1% | 0.07% | +27.8% |
SGTX | SIGILON THERAPEUTICS INC | $2,961,000 | -52.0% | 276,000 | 0.0% | 0.06% | -45.0% | |
KNTE | KINNATE BIOPHARMA INC | $2,910,000 | -25.3% | 125,000 | 0.0% | 0.06% | -14.5% | |
AXLA | AXCELLA HEALTH INC | $2,857,000 | -15.8% | 712,500 | 0.0% | 0.06% | -3.3% | |
MEIP | Buy | MEI PHARMA INC | $2,850,000 | +9.3% | 1,000,000 | +31.6% | 0.06% | +26.1% |
CGEM | CULLINAN ONCOLOGY INC | $2,575,000 | -38.2% | 100,000 | 0.0% | 0.05% | -29.7% | |
KDNY | CHINOOK THERAPEUTICS INC | $2,549,000 | -9.1% | 180,500 | 0.0% | 0.05% | +4.0% | |
YMTX | YUMANITY THERAPEUTICS INC | $2,533,000 | -35.6% | 217,391 | 0.0% | 0.05% | -27.1% | |
LVTX | LAVA THERAPEUTICS NV | $2,176,000 | -28.4% | 200,000 | 0.0% | 0.04% | -18.5% | |
MOLN | New | MOLECULAR PARTNERS AGads | $2,049,000 | – | 100,000 | +100.0% | 0.04% | – |
CHMA | CHIASMA INC | $1,797,000 | +51.1% | 380,000 | 0.0% | 0.04% | +71.4% | |
IRWD | IRONWOOD PHARMACEUTICALS INC | $1,423,000 | +15.1% | 110,532 | 0.0% | 0.03% | +31.8% | |
RIGL | RIGEL PHARMACEUTICALS INC | $1,394,000 | +27.0% | 321,100 | 0.0% | 0.03% | +47.4% | |
CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $1,145,000 | +233.8% | 79,600 | 0.0% | 0.02% | +283.3% | |
SURF | SURFACE ONCOLOGY INC | $746,000 | -4.4% | 100,000 | 0.0% | 0.02% | +7.1% | |
LU | New | LUFAX HOLDING LTD | $565,000 | – | 50,000 | +100.0% | 0.01% | – |
CDTX | CIDARA THERAPEUTICS INC | $454,000 | -24.1% | 224,675 | 0.0% | 0.01% | -18.2% | |
MANU | Exit | MANCHESTER UTD PLC NEWord cl a | $0 | – | -12,488 | -100.0% | -0.00% | – |
PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -75,000 | -100.0% | -0.03% | – |
XLE | Exit | SELECT SECTOR SPDR TRcall | $0 | – | -50,000 | -100.0% | -0.04% | – |
SHLS | Exit | SHOALS TECHNOLOGIES GROUP INcl a | $0 | – | -100,000 | -100.0% | -0.06% | – |
GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -100,000 | -100.0% | -0.14% | – |
TCOM | Exit | TRIP COM GROUP LTDads | $0 | – | -250,000 | -100.0% | -0.18% | – |
TME | Exit | TENCENT MUSIC ENTMT GROUPsponsored ads | $0 | – | -550,000 | -100.0% | -0.20% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -150,000 | -100.0% | -0.20% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.22% | – |
Z | Exit | ZILLOW GROUP INCcl c cap stk | $0 | – | -100,000 | -100.0% | -0.23% | – |
KWEB | Exit | KRANESHARES TRcall | $0 | – | -200,000 | -100.0% | -0.27% | – |
CPNG | Exit | COUPANG INCcl a | $0 | – | -400,000 | -100.0% | -0.35% | – |
SLB | Exit | SCHLUMBERGER LTDcall | $0 | – | -1,000,000 | -100.0% | -0.48% | – |
BEKE | Exit | KE HLDGS INCsponsored ads | $0 | – | -600,000 | -100.0% | -0.60% | – |
AVGO | Exit | BROADCOM INC | $0 | – | -75,000 | -100.0% | -0.61% | – |
CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -750,000 | -100.0% | -0.68% | – |
AA | Exit | ALCOA CORPcall | $0 | – | -1,500,000 | -100.0% | -0.86% | – |
INTC | Exit | INTEL CORP | $0 | – | -800,000 | -100.0% | -0.90% | – |
XBI | Exit | SPDR SER TRcall | $0 | – | -500,000 | -100.0% | -1.20% | – |
BAC | Exit | BK OF AMERICA CORPcall | $0 | – | -2,000,000 | -100.0% | -1.37% | – |
BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -900,000 | -100.0% | -1.74% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AGENUS INC | 42 | Q3 2023 | 1.9% |
IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
BEIGENE LTD | 28 | Q3 2023 | 7.4% |
BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-25 |
4 | 2024-03-13 |
4 | 2024-02-29 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-13 |
4 | 2023-10-16 |
13F-HR | 2023-08-11 |
4 | 2023-06-22 |
3 | 2023-06-15 |
4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.